3-(4-piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as figands for the ORL-1 receptor

被引:15
作者
Bignan, Gilles C.
Battista, Kathleen
Connolly, Peter J.
Liu, Jingchun
Middleton, Steven A.
Reitz, Allen B.
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA
[2] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
关键词
ORL-1; nociceptin; opioid receptor-like (ORL); orphanin FQ (OFQ); N/OFQ peptide (NOP); agonist; indole; piperidine; pyridine; anxiety; stress; learning; memory;
D O I
10.1016/j.bmcl.2006.03.094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of indoles and 1H-pyrrolo[2,3-b]pyridines having a piperidine ring at the 3-position were synthesized and found to bind with high affinity to the ORL-1 receptor. Structure-activity relationships at the piperidine nitrogen were investigated in each series. Substitution on the phenyl ring and nitrogen atom of the indole and 1H-pyrrolo[2,3-b]pyridine cores generated several selective high-affinity ligands that were agonists of the ORL-1 receptor. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3524 / 3528
页数:5
相关论文
共 30 条
[1]   Preparation of 3-spirocyclic indolin-2-ones as ligands for the ORL-1 receptor [J].
Bignan, GC ;
Battista, K ;
Connolly, PJ ;
Orsini, MJ ;
Liu, JC ;
Middleton, SA ;
Reitz, AB .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) :5022-5026
[2]   Recent advances towards the discovery of ORL-1 receptor agonists and antagonists [J].
Bignan, GC ;
Connolly, PJ ;
Middleton, SA .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (04) :357-388
[3]  
CAI H, 2002, Patent No. 014317
[4]  
CAI H, 2002, Patent No. 020013
[5]   The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats [J].
Ciccocioppo, R ;
Economidou, D ;
Fedeli, A ;
Massi, M .
PHYSIOLOGY & BEHAVIOR, 2003, 79 (01) :121-128
[6]   Opioid receptor signalling mechanisms [J].
Connor, M ;
Christie, MJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (07) :493-499
[7]  
CRAWFORTH JM, 2000, Patent No. 004017
[8]  
EDWARDS L, 2001, Patent No. 012629
[9]  
FELDING J, 2002, Patent No. 008223
[10]   Synthesis and structure-activity relationships of novel histamine H1 antagonists:: Indolylpiperidinyl benzoic acid derivatives [J].
Fonquerna, S ;
Miralpeix, M ;
Pagès, L ;
Puig, C ;
Cardús, A ;
Antón, F ;
Cárdenas, A ;
Vilella, D ;
Aparici, M ;
Calaf, E ;
Prieto, J ;
Gras, J ;
Huerta, JM ;
Warrellow, G ;
Beleta, J ;
Ryder, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6326-6337